Aldehídos

Please enquire for more information about 5,6,7,8-Tetrahydronaphthalene-1-carbaldehyde including the price, delivery time and more detailed product information at the technical inquiry form on this page

3-(Trifluoromethyl)benzaldehyde is an organic compound that has the chemical formula C8H7FO. It is a trifunctional molecule with three phenolic hydroxyl groups, which makes it a good candidate for drug design. 3-(Trifluoromethyl)benzaldehyde can be synthesized by reacting an imine with a chiral acid chloride in the presence of a base and a catalytic amount of DMAP. The reaction yield is low, but this synthetic method is efficient. 3-(Trifluoromethyl)benzaldehyde has been shown to inhibit the growth of Mycobacterium avium, but not Mycobacterium tuberculosis or other bacteria such as Listeria monocytogenes and Escherichia coli. This might be due to its ability to inhibit protein synthesis by binding to ribosomes. This compound also possesses anti-inflammatory properties and inhibits leukemia Hl-

2-Cyanobenzaldehyde is an aldehyde that reacts with nucleophiles such as trifluoromethanesulfonic acid to form a molecule. 2-Cyanobenzaldehyde has potent inhibitory activity against the kinase glycogen synthase kinase 3 (GSK3) and can be used to treat autoimmune diseases. It also reacts with hydrochloric acid in solution to form an intermediate, which is then reacted with glycine and ATP to produce a chiral compound. The product of this reaction has been shown to be active methylene, which was synthesized by asymmetric synthesis.

Please enquire for more information about 4-Bromobenzaldehyde including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about 2-Methyl-6-(trifluoromethyl)nicotinaldehyde including the price, delivery time and more detailed product information at the technical inquiry form on this page

1-Phenyl-1H-pyrazole-4-carbaldehyde is an antibacterial agent that has been shown to have bactericidal activity against bacteria. It inhibits the growth of bacteria by binding to the pyrazole ring in the bacterial cell wall and blocking the formation of a hydrogen bond. 1-Phenyl-1H-pyrazole-4-carbaldehyde has been shown to be effective against methicillin resistant Staphylococcus aureus (MRSA) and Ciprofloxacin resistant Pseudomonas aeruginosa isolates, but not against Mycobacterium tuberculosis or Mycobacterium avium complex.

1-H-Pyrazole-3-carboxaldehyde (1HP) is a β-unsaturated ketone that has been shown to inhibit the growth of chronic pulmonary fungal infections, such as histoplasmosis, coccidioidomycosis, and blastomycosis. It has also been shown to have anticancer activity in vitro and in vivo. 1HP inhibits cellular proliferation by inducing cell cycle arrest at the G(2)/M checkpoint. The molecular mechanism of this inhibition is due to an increase in the expression of p21 protein and p27 protein, which are tumor suppressor proteins that regulate progression through the cell cycle. 1HP also inhibits HIV infection by inhibiting reverse transcriptase and proteases, which are enzymes involved in viral replication. This compound binds to active methylene groups on the enzyme's surface, blocking its ability to perform chemical reactions with other molecules. 1HP also has strong inhibitory effects on cancer cells because it causes structural

5-Bromo-2-hydroxybenzaldehyde is an organic compound with a chemical formula of CHBrO. It is a white solid that is soluble in water, ethanol, and acetone. The synthesis of 5-bromo-2-hydroxybenzaldehyde has been achieved by the acylation reaction of benzaldehyde with bromide ion. The selectivity for this reaction can be increased by using sodium borohydride as a reducing agent instead of lithium aluminum hydride. This method can be applied to the synthesis of salmeterol, which is used as a medicine in the treatment of asthma.

Angiotensin-converting enzyme inhibitor; anti-hypertensive

Z-Leu-Leu-Nle (ZLL) is a small molecule that selectively inhibits the activity of the aspartyl protease, BACE1, which is an enzyme that cleaves amyloid precursor protein (APP) to produce amyloid beta peptides. The inhibition of this enzyme has been shown to be effective in preventing or delaying the onset of Alzheimer's disease. ZLL also inhibits estrogen receptor alpha and has antiestrogenic effects in breast cancer cells. This compound induces apoptosis by binding to apoptotic proteins, such as tumor necrosis factor receptor 1, Fas ligand, and TRAIL receptors. It also inhibits cell growth and induces chemoresistance in breast cancer cells.

3-Fluoro-2-nitrobenzaldehyde is a pyridine derivative that has been used in the synthesis of a number of important heterocyclic compounds. This compound can be prepared by reacting 3,4-dichloroaniline with nitrous acid and then hydrolyzing the resulting 3-chloroquinoline with hydrochloric acid. The reaction yields anilines and quinolines in regiospecifically, as well as formylation, cyclisation, and condensation products. It is also capable of aromatisation reactions with benzene to produce benzofuran derivatives.

3,5-Dimethylbenzaldehyde is an organic compound that is a colorless liquid. It has a chemical formula of C9H12O2 and is classified as an aldehyde. 3,5-Dimethylbenzaldehyde can be synthesized by the reaction of isopropyl palmitate with xylene in the presence of carbon as a source. The reaction time required for this synthesis is approximately one day. The major products of this reaction are 3,5-dimethylbenzaldehyde and 2-methylbutanal. This reaction mechanism can also be used to determine the concentration of urinary metabolites in human urine samples. Analysis of these samples requires an organic solvent such as hexane or dichloromethane. Kinetic data was collected from the rate at which zinc powder reacts with 3,5-dimethylbenzaldehyde over time at different concentrations. A kinetic experiment was conducted using c–h bond activation to produce 3,5-dimethoxy

2-Bromo-6-methylpyridine-3-carboxaldehyde (BMPCA) is a pharmacological agent that belongs to the group of antagonists. It has been shown to be a potent antagonist at the NMDA receptor and may be used for treating neuropathic pain. BMPCA also has been shown to have competitive inhibition at the naphthyridine receptor, which may allow it to act as an antagonist or an agonist depending on its binding site. The regioisomeric analogs of BMPCA are 2-(2,5-dichloropyridyl)-6-methylpyridine-3-carboxaldehyde and 2-(2,5-dimethylpyridyl)-6-methylpyridine-3-carboxaldehyde. These analogs have been shown to inhibit the growth of tumor cells in vitro and in vivo.

2-Methyl-5-nitrobenzaldehyde is a nitro compound that is used in the synthesis of dobutamine. It has been shown to undergo rearrangements, with the formation of 2-methyl-5-nitrophenol. Kinetic studies have shown that chlorine can be substituted for hydrogen at the 2 position, and this substitution leads to an increase in reactivity. 2-methyl-5-nitrobenzaldehyde also reacts with dopamine to form a ketone. The hydroxy group on this molecule is nucleophilic and can attack electrophiles, making it useful as an active site for synthetic reactions. This compound is also pyrophoric, which means it will spontaneously ignite in air and burn until all its fuel is consumed.

Phenylpropargylaldehyde is an organic compound that is a chiral molecule, which means it has two enantiomers. It was first synthesized in 1964 by R.B. Woodward and T.W. Rittenberg at the University of Chicago, and is used as a chemical intermediate in the synthesis of other compounds with biological activity such as matrix metalloproteinase inhibitors, for example marimastat. Phenylpropargylaldehyde can be prepared from malonic acid and phenylboronic acid in a reaction mechanism that involves nucleophilic substitutions, carbonyl group activation and hydrogen bonding to lysine residues on proteins. The asymmetric synthesis of this compound has been shown to suppress genes associated with metabolic disorders such as diabetes mellitus type 2, fatty acid metabolism disorders and endocrine disorders (e.g., thyroid). It also has adjuvant therapeutic properties in cancer treatment, especially when combined with synthetic fatty acids such as oleic acid or ar

Please enquire for more information about Z-Ile-Leu-aldehyde including the price, delivery time and more detailed product information at the technical inquiry form on this page

2-Amino-4-fluorobenzaldehyde is a plant growth regulator that has been shown to be effective at increasing the yield of flowers and fruit crops. It is used as an intermediate in the synthesis of agrochemicals, such as 2-aminobenzaldehyde and anthranilic acid. The biosynthesis of 2-amino-4-fluorobenzaldehyde starts from methanol and intermediates such as anthranilic acid, aminoaldehydes, or alcohols. It can also be produced by oxidative coupling of 2-aminobenzaldehyde with phenylacetone in the presence of sodium hydroxide. 2-Amino-4-fluorobenzaldehyde has been shown to be more efficient than other plant growth regulators such as robinia or aminocyclopentane carboxylic acid (ACC).

Z-Ile-Glu(OtBu)-Ala-Leu-aldehyde, also known as ZILEAL, is a potent immunosuppressant that binds to the Toll-like receptor (TLR) and inhibits NF-κB binding activity. It has been shown to reduce the activation of macrophages by inhibiting the production of proinflammatory cytokines such as tumor necrosis factor alpha (TNFα), IL-1β, and IL-6. This drug has been shown to inhibit HIV replication in vitro and was also found to have an antiviral effect against herpes simplex virus type 1 in vivo. ZILEAL also inhibits dsDNA binding activity, which may have potential applications in cancer treatment.

Betulinaldehyde is a natural compound that belongs to the group of betulinic acid. It has been shown to have antimicrobial activity against oral pathogens and has been shown to inhibit the growth of bacteria by reacting with their cell walls. Betulinaldehyde has also been shown to have an effect on autoimmune diseases such as multiple sclerosis, as well as infectious diseases such as HIV and tuberculosis. Betulinaldehyde can be extracted from the bark of birch trees using acetate, which is then reacted with hydrogen peroxide in a reaction solution. The resulting product is purified using preparative high-performance liquid chromatography (HPLC).

3-Nitroisonicotinaldehyde is a kinase inhibitor that binds to the ATP binding site of receptor tyrosine kinases. It inhibits the activation of these receptors and prevents the phosphorylation of tyrosine residues on the receptor. 3-Nitroisonicotinaldehyde has been shown to inhibit VEGFR-2, ABCG2, and efflux in human cancer cells. This drug has been shown to inhibit tumor growth in mice by inhibiting angiogenesis, which is a process that involves the formation of new blood vessels from pre-existing ones. 3-Nitroisonicotinaldehyde also inhibits tumor growth by blocking the production of vascular endothelial growth factor (VEGF) from angiogenic cells.

Perillaldehyde is a natural compound that has been used in food and medicine for centuries. It is an antimicrobial agent with dextran sulfate, which is a sugar polymer that inhibits the growth of fungi and bacteria. Perillaldehyde also has been shown to inhibit the energy metabolism of microorganisms by decreasing ATP production. Perillaldehyde has also been shown to have genotoxic activity, as it can cause DNA strand breaks. This compound also causes oxidative stress in cells by reducing mitochondrial membrane potential and inducing reactive oxygen species (ROS). Perillaldehyde has acute toxicities, as it causes electrochemical impedance spectroscopy changes that indicate cell death.

2,3,5-Trichlorobenzaldehyde is a chemical compound that has been shown to have anticancer and apoptotic effects. It inhibits the growth of bacteria by chelating iron ions and inhibiting bacterial dna synthesis. 2,3,5-Trichlorobenzaldehyde has also been shown to inhibit the growth of cancer cells in culture in an experimental study. This chemical has been used as a substrate for nmr spectroscopy to study its functional groups and radical scavenging activities. 2,3,5-Trichlorobenzaldehyde can be synthesized from phenacyl chloride and benzaldehyde in the presence of hydrogen chloride gas. The carbonyl group in 2,3,5-trichlorobenzaldehyde may cause metabolic disorders such as diabetes mellitus or hyperglycemia.